ranitidine has been researched along with Ovarian Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, T; Komatsu, M; Kumagai, M; Kusuda, T; Naitou, H; Shinkou, S; Takehara, K | 1 |
| Barakat, R; Curtin, J; Francis, P; Hakes, T; Jones, W; Lewis, JL; Markman, M; Reichman, B; Rowinsky, E; Rubin, S | 1 |
| Boehm, DK; Maksymiuk, AW | 1 |
| Giannikos, L; Gogas, J; Kosmas, C; Polyzos, A; Tsavaris, N | 1 |
| Goram, AL; Richmond, PL | 1 |
| Elit, L; Finn, M; Hirte, H; Kwon, JS; Mazurka, J; Moens, F; Trim, K | 1 |
| Ali, MJ; Badner, NH; Watson, JT | 1 |
3 trial(s) available for ranitidine and Ovarian Neoplasms
| Article | Year |
|---|---|
Intraperitoneal Taxol (paclitaxel) in the management of ovarian cancer.
Topics: Dexamethasone; Diphenhydramine; Drug Administration Schedule; Female; Humans; Injections, Intraperitoneal; Neutropenia; Ovarian Neoplasms; Paclitaxel; Premedication; Ranitidine; Treatment Outcome | 1994 |
Paclitaxel premedication regimens.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cimetidine; Dexamethasone; Drug Hypersensitivity; Female; Glucocorticoids; Histamine H2 Antagonists; Humans; Infusions, Intravenous; Ovarian Neoplasms; Paclitaxel; Premedication; Ranitidine | 1996 |
A feasibility study of 1-h paclitaxel infusion in patients with solid tumors.
Topics: Aged; Antineoplastic Agents, Phytogenic; Bone Marrow; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Central Nervous System; Dexamethasone; Feasibility Studies; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Paclitaxel; Premedication; Promethazine; Ranitidine; Safety | 1997 |
4 other study(ies) available for ranitidine and Ovarian Neoplasms
| Article | Year |
|---|---|
[Paclitaxel plus carboplatin in ovarian cancer-comparison of adverse effects between monthly and weekly administration].
Topics: Adult; Aged; Anorexia; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dexamethasone; Diarrhea; Diphenhydramine; Drug Administration Schedule; Female; Humans; Leukopenia; Middle Aged; Nausea; Ovarian Neoplasms; Paclitaxel; Ranitidine; Retrospective Studies; Thrombocytopenia | 2004 |
Pegylated liposomal doxorubicin: tolerability and toxicity.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Diphenhydramine; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Granisetron; Hematologic Diseases; Humans; Liposomes; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Ovarian Neoplasms; Paresthesia; Premedication; Prochlorperazine; Ranitidine; Stomatitis; Tamoxifen; Treatment Failure | 2001 |
A comparison of two prophylactic regimens for hypersensitivity reactions to paclitaxel.
Topics: Administration, Oral; Cohort Studies; Dexamethasone; Diphenhydramine; Drug Hypersensitivity; Female; Glucocorticoids; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Injections, Intravenous; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Ranitidine; Retrospective Studies | 2002 |
The prophylactic use of octreotide in a patient with ovarian carcinoid and valvular heart disease.
Topics: Anesthesia, Inhalation; Anesthesia, Intravenous; Carcinoid Tumor; Female; Heart Valve Diseases; Humans; Intraoperative Complications; Middle Aged; Octreotide; Ovarian Neoplasms; Premedication; Ranitidine | 1990 |